Ophthalmology · Freehold, NJ
NPI
1225359847
Since 2010
Specialty
Ophthalmology
Code 207W00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
500 W Main St
Freehold, NJ, 07728
Phone (732) 462-8707
Groups this clinician bills Medicare through
Medicare paid, 2024
$248K
2,446 services
Medicare patients, 2024
806
Average age 78
Drug cost, 2024
$457K
3,157 prescriptions
Company payments, 2025
$295
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David K Lee was code 99213 (office e&m - established), 380 times for 308 patients. In total David K Lee billed 2,446 services in 29 codes, and Medicare paid $248K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-07-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 380 | 308 | $78.25 | $30K |
| 99214 Office E&M - Established | Office | 363 | 358 | $106.28 | $39K |
| 92012 Ophthalmological E&M | Office | 306 | 265 | $56.78 | $17K |
| 92014 Ophthalmological E&M | Office | 273 | 271 | $79.30 | $22K |
| 92083 Vision, Hearing, and Speech Services | Office | 262 | 260 | $48.18 | $13K |
| 92133 Computerized Ophthalmic Imaging | Office | 254 | 252 | $25.54 | $6,486 |
| 92136 Ultrasound - Nonspecific | Office | 145 | 104 | $31.88 | $4,623 |
| 66984 Cataract Surgery | Facility | 87 | 56 | $480.90 | $42K |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 59 | 18 | $53.90 | $3,180 |
| 66982 Cataract Surgery | Facility | 51 | 40 | $651.45 | $33K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 46 | 45 | $14.13 | $650 |
| 66821 Cataract Surgery | Office | 36 | 30 | $281.93 | $10K |
| 99427 Chronic, Principal, and Transitional Care Management | Office | 31 | 15 | $41.70 | $1,293 |
| 92134 Computerized Ophthalmic Imaging | Office | 27 | 25 | $31.40 | $848 |
| 66761 Fluid Flow and Drainage of Eye (Any Method) | Office | 24 | 17 | $242.08 | $5,810 |
By year: 2022 $243K for 2,347 services; 2023 $280K for 2,713 services; 2024 $248K for 2,446 services.
Medicare prescription drug claims, 2024
In 2024, the drug David K Lee prescribed most often to Medicare patients was Latanoprost, with 820 prescriptions and refills. In total David K Lee wrote 3,157 Medicare prescriptions that cost $457K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 820 | 1,963 | 247 | $11K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 329 | 705 | 96 | $6,382 |
| Prednisolone Acetate Generic | 282 | 328 | 190 | $13K |
| Timolol Maleate Generic | 243 | 691 | 92 | $4,240 |
| Ketorolac Tromethamine Generic | 214 | 247 | 122 | $2,820 |
| Lumigan Bimatoprost | 167 | 343 | 48 | $86K |
| Polymyxin B Sul-Trimethoprim Polymyxin B Sulf/Trimethoprim | 155 | 186 | 112 | $999 |
| Brimonidine Tartrate Generic | 112 | 255 | 37 | $7,660 |
| Dorzolamide Hcl Generic | 66 | 137 | 20 | $1,375 |
| Travoprost Generic | 65 | 158 | 17 | $16K |
| Rocklatan Netarsudil Mesylat/Latanoprost | 61 | 92 | 13 | $34K |
| Restasis Cyclosporine | 61 | 147 | 23 | $89K |
| Cyclopentolate Hcl Generic | 56 | 57 | 50 | $562 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 46 | 102 | 11 | $12K |
| Combigan Brimonidine Tartrate/Timolol | 43 | 99 | 12 | $25K |
Brand drugs: 1,056 claims; generic drugs: 2,101 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David K Lee $295 ($295 in general payments such as food, travel and fees) from 6 companies. The largest payer was Alcon Vision LLC with $181.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.